5 EASY FACTS ABOUT KT-474 DESCRIBED

Dosages need to be individualized according to the proposed goal of therapy plus the patient’s response.Rhabdomyolysis with renal dysfunction secondary to myoglobinuria are already documented with other HMG-CoA reductase inhibitors. This has not been documented with cerivastatin sodium up to now. Cerivastatin therapy really should be discontinued